TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 4 Mar 2021, 22:56 GMT

Official UK procurement notice

Human Leucocyte Antigen (HLA) specific Antibody detection and definition systems

Official notice

Authority: NHS Blood and Transplant (Central government)

Framework agreement2 lotsGoodsOpen procedure
Sectors: Medical Devices & Pharma (33)Laboratory, optical and precision equipments (excl. glasses) (38)Repair & Maintenance (50) Delivery: UK
Framework ceiling (notional)Value not publishedframework ceiling, not attributable revenue
Awarded 1 Mar 2021
Lots 2see the lot list below

What is being bought2 lots · detail below

Published requirement description

Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas:

  • Solid organ transplantation and clinical advice for donor selection
  • Haematopoietic stem cell transplantation and clinical advice for donor selection
  • Blood transfusion and transfusion reactions (SHOT)
  • Platelet refractoriness and provision of HLA/ HPA selected components
  • Platelet immunology
  • Granulocyte immunology
  • Immunogenetics including diagnostic testing and pharmacogenetics
  • Haematopoietic stem cell donor registry typing

NHSBT require Human Leukocyte Antigen (HLA) antibody detection and definition systems. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA antibody detection and definition in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve.

We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve.

For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement.

The Framework Agreement was awarded for 4 years and divided into lots as follows:

Lot 1 - HLA Antibody Detection and Definition Systems - awarded to VH Bio Ltd and Immucor

Lot 2 - Maintenance of Existing Luminex Systems - awarded to Immucor

CPV: Biomedical equipment · Diagnostic kits · Medical consumables · Medical equipments · Repair and maintenance services of medical equipment

How this framework works

From the published notice
Bids received
3 bids on the busiest of 2 lots · 2 suppliers appointed

Lots and requirements (2)Procurement structure

2 lots · no lot values published
Lot #1HLA Antibody Detection and Definition SystemsAwarded
Delivery: UK
33100000 Medical equipments33140000 Medical consumables33141625 Diagnostic kits38434540 Biomedical equipment50421000 Repair and maintenance services of medical equipment
Lot #2Maintenance of Existing Luminex SystemsAwarded
Delivery: UK
50421000 Repair and maintenance services of medical equipment

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
What this means for your bid
  • “Human Leucocyte Antigen (HLA) specific Antibody detection and…” is a framework: the contest is a place on its panel, not a single contract.

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
4 Mar 2021, 22:56 GMT
Last source update
4 Mar 2021, 22:56 GMT
Authority reference
NHSBT1249
FTS notice number
2021/S 000-004395
Classification (CPV)
Biomedical equipmentDiagnostic kitsMedical consumablesMedical equipmentsRepair and maintenance services of medical equipment
Delivery area
UK
Official registry OCID
ocds-h6vhtk-029880 Find a Tender

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 2admitted to the panel · see the list ↓
Bids received 3busiest of 2 lots
Contracts signed 2latest 1 Mar 2021

2 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

  • Maintenance of Existing Luminex Systems

    Signed
    1 Mar 2021
    Value
    £123,000
    Status
    active

  • HLA Antibody Detection and Definition Systems

    Signed
    22 Feb 2021
    Value
    £7,020,000
    Status
    active

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · HLA Antibody Detection and Definition Systems3bids———
2 · Maintenance of Existing Luminex Systems2bids———

Contracting authority & participating public bodies

NHS Blood & Transplant

Contracting authorityCentral GovernmentBody governed by public lawHealth North Bristol Park, Filton, Bristol, UK, BS34 7QHContact email

Dispute resolution & review bodies

Framework contractors & participating bidders

2 commercial parties on the notice

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.